EPISOMAL VECTORS FOR STABLE PRODUCTION OF RECOMBINANT PROTEINS AND ENGINEERED ANTIBODIES
Abstract
There is tremendous interest in the production of recombinant proteins, particularly bispecific antibodies and antibody-drug conjugates for research and therapeutic use. Here, we demonstrate a highly versatile plasmid system that allows rapid generation of stable Expi293 cell pools by episomal retention of transfected DNA. By linking protein expression to puromycin resistance though an attenuated internal ribosome entry site, we achieve stable cell pools producing proteins of interest. In addition, split intein-split puromycin-mediated selection of two separate protein expression cassettes allows the stable production of bispecific antibody-like molecules or antibodies with distinct C-terminal heavy chain modifications, such as an antigen on one chain and a sortase tag on the other chain. We also use this novel expression system to generate stable Expi293 cell pools that secrete sortase A {Delta}59 variant Srt4M. Using these reagents, we prepared a site-specific drug-to-antibody ratio of 1 antibody-siRNA conjugate. We anticipate the simple, robust, and rapid stable protein expression systems described here being useful for a wide variety of applications.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 0.55
- Field percentile
- top 45%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An improved workflow for rapid, large-scale protein production in HEK293 cells via antibiotic enrichment after lentiviral transduction
Ester Behiels, Anushka Nair, … Jonathan Elegheert·bioRxiv·Mar 8, 2026
- Rapid and cost-effective development of stable clones for the production of anti-Ebola monoclonal antibodies in HEK293T cells
E. Gonzalez-Gonzalez, I. Palestino-Diaz, … M. M. Alvarez·bioRxiv·Apr 21, 2020
- Augmenting Recombinant Antibody Production in HEK293E Cells: Optimising Transfection and Culture Parameters
Zealyn Shi‐Lin Heng, Joshua Yi Yeo, … Wei‐Li Ling·Antibody TherapeuticsPeer-reviewed·Jan 1, 2022
- Production of high-affinity glycosylated anti-mouse conjugated nanobodies in Pichia pastoris
Sofía Orioli, Javier Santos, … Cecilia D’Alessio·Frontiers in Bioengineering and BiotechnologyPeer-reviewed·Oct 15, 2025
- Production and assessment of monoclonal antibodies against the SpyCas9 protein of Streptococcus pyogenes
Mi-Jin Park, Jongjin Park, … Sunghwa Choe·bioRxiv·Jan 2, 2021
- In Vivo Production of a Protein via the Delivery of Plasmid DNA by Computationally Designed Polymer Nanoparticles (PNP)
John D. Fisher, Shannon R. Petersen, … Shashi K. Murthy·bioRxiv·Feb 14, 2025